cathepsin k inhibitor combinations and a bisphophonate used in the treatment of bone metastases, tumor growth and tumor induced bone loss

摘要

"the combination of an inhibitor of cathepsin k and bisphosphonate therapy in the treatment of bone metastase to development of cancer cells and the bone loss induced by a tumor, the present invention relates to pharmaceutical preparations comprising certain types of b isphosphonates and certain types of cathepsin k inhibitors.especially in the prevention and treatment of bone metastases and hypercalcemia induced by a tumor, tumor development, tumor induced bone loss and bone loss caused by diseases such as osteoporosis, bone loss due ite in anticancer therapy.